GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Genpharmasec Ltd

Genpharmasec Ltd Board Meeting to Approve Audited Financial Results

BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 13 May 2026, 11:37 AM IST  ·  BSE ID: a6756678-8eb0-4e96-920f-eab1402dbe12
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet on May 21, 2026, to approve its financial results for the last quarter and full year.
🤖 AI Summary
  • Genpharmasec Ltd scheduled a Board Meeting on Thursday, May 21, 2026.
  • Meeting agenda includes approving Audited Standalone and Consolidated Financial Results.
  • Results pertain to the Quarter and Year ended March 31, 2026.
  • Trading window closed from April 1, 2026, until 48 hours post-results declaration.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time.
👤
Who Is Affected
All shareholders are affected as the company prepares to disclose its full fiscal year financial performance, which will be available post the board meeting.
🔍
Management Signal
The management is adhering to regulatory requirements by intimating the board meeting for financial result approval and implementing a trading window closure.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board Meeting outcome filing — check for approved financial results details.
Auditor's Report — review any qualifications or key observations.
Full financial results disclosure — analyze standalone and consolidated performance.
LOW RISK The filing is a routine board meeting intimation, carrying minimal inherent risk.
💡 Investor Takeaway
Genpharmasec Ltd has intimated a Board Meeting on May 21, 2026, to consider and approve its Audited Standalone and Consolidated Financial Results for the Quarter and Year ended March 31, 2026. The trading window is currently closed for designated persons.
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.